Son güncelleme :
19/11/2024
Araştırma Takımlar - R&D Division, Biotechnology Research Institute, Celltrion   pdf  
Güney Kore
ilaç laboratuvar
R&D Division, Biotechnology Research Institute, Celltrion
Incheon
Email
Kaynaklar   Kaynaklar   (2)  
1
Investigation of the Physicochemical and Biological Stability of the Adalimumab Biosimilar CT-P17.
Kyeong Shin Y, Yong Han W, Jung Kim S, Woo Kim K, Won Ro J, Bin Lee J, Seok Oh J, Astier A. (YeonKyeong.Shin@celltrion.com)
Adv Ther - 2021 - ; 38 : 5609–5622
2
In-Use Physichochemical and Biological Stability of the Trastuzumab Biosimilar CT-P6 Upon Preparation for Intravenous Infusion.
Kim S.J, Lee J.W, Kang H.Y, Kim S.Y, Shin Y.K, Kim K.W, Oh J.S, Lim K.J, Kim J.Y. (SuJung.Kim@celltrion.com)
Bio Drugs - 2018 - 32;619-625

Listeler   moleküller okudu   (2)  
Immünosupresan Enjeksiyon Adalimumab
kanser ilaç Enjeksiyon Trastuzumab

  Mentions Légales